Drug Trials Snapshots: OJEMDA
Summary
Drug Trials Snapshots: OJEMDA is a kinase inhibitor that is used to treat patients 6 months of age and older with relapsed or refractory pediatric low-grade gli...
Description
Drug Trials Snapshots: OJEMDA is a kinase inhibitor that is used to treat patients 6 months of age and older with relapsed or refractory pediatric low-grade gli...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source